The impact of seasonal influenza vaccination uptake on COVID-19 vaccination attitudes in a rural area in Greece.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
16 01 2023
Historique:
received: 09 11 2022
revised: 10 12 2022
accepted: 12 12 2022
pubmed: 19 12 2022
medline: 4 1 2023
entrez: 18 12 2022
Statut: ppublish

Résumé

Promoting vaccination for coronavirus disease 2019 (COVID-19), especially for high-risk groups such as the elderly and persons with comorbidities, is important for reducing the incidence of severe disease and death. Retrospective cross-sectional study of factors associated with COVID-19 vaccination, including previous influenza vaccination, among all persons who received medical services in a rural area in Crete, Greece, between October 2020-May 2021. Among 3129 participants, receipt of influenza vaccination in 2020-21 was strongly associated with COVID-19 vaccination, as was influenza vaccination in 2019-20, albeit to a lesser extent. In addition, persons older than 59 years (with exception of those 90 + years old) and those who lived closer to the hospital/health center, were more likely to vaccinate for COVID-19. Persons younger than 40 years of age, females, persons with mental illness or neurologic disease, were also less likely to vaccinate for COVID-19 (all p < 0.001). COVID-19 vaccination was more likely among those who were vaccinated for influenza before and during the pandemic. Access to healthcare services and specific comorbidities, were important influencers for vaccination, underlying the importance of tailored interventions to enforce vaccination in high-risk groups.

Identifiants

pubmed: 36529592
pii: S0264-410X(22)01539-0
doi: 10.1016/j.vaccine.2022.12.024
pmc: PMC9750889
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0
Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

821-825

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Pharmaceuticals (Basel). 2022 Mar 08;15(3):
pubmed: 35337120
Lancet. 2021 Dec 11;398(10317):2186-2192
pubmed: 34793741
Vaccine. 2021 Apr 8;39(15):2024-2034
pubmed: 33722411
Cochrane Database Syst Rev. 2021 Jul 20;7:CD013706
pubmed: 34282603
Vaccines (Basel). 2022 Mar 03;10(3):
pubmed: 35335020
BMC Public Health. 2022 Sep 2;22(1):1667
pubmed: 36056325
Int J Clin Pract. 2021 Apr;75(4):e13915
pubmed: 33969593
Vaccines (Basel). 2021 Oct 25;9(11):
pubmed: 34835174
Front Public Health. 2021 Aug 13;9:698111
pubmed: 34485229
Z Gesundh Wiss. 2022 Sep 19;:1-17
pubmed: 36160668
Front Psychiatry. 2022 Jan 13;12:798554
pubmed: 35095612
EClinicalMedicine. 2021 Oct;40:101113
pubmed: 34490416
Lancet. 2021 May 15;397(10287):1819-1829
pubmed: 33964222

Auteurs

Andria Papazachariou (A)

Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Greece; Department of Internal Medicine, General Hospital of Sitia, Sitia, Greece.

Constantinos Tsioutis (C)

School of Medicine, European University Cyprus, Nicosia, Cyprus.

Theodore Lytras (T)

School of Medicine, European University Cyprus, Nicosia, Cyprus.

Onoufrios Malikides (O)

Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Greece.

Maria Stamatelatou (M)

Department of Internal Medicine, General Hospital of Sitia, Sitia, Greece.

Nektaria Vasilaki (N)

Department of Internal Medicine, General Hospital of Sitia, Sitia, Greece.

Athanasia Milioni (A)

Department of Otorhinolaryngology, "Elpis" General Hospital, Athens, Greece.

Maria Dasenaki (M)

Department of Internal Medicine, General Hospital of Sitia, Sitia, Greece.

Nikolaos Spernovasilis (N)

School of Medicine, University of Crete, Heraklion, Greece; Department of Infectious Diseases, German Oncology Center, Limassol, Cyprus. Electronic address: nikspe@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH